SLS-002
Showing 1 - 25 of 359
Depressive Disorder, Major, Suicidal Trial in United States (drug, other, device)
Recruiting
- Depressive Disorder, Major
- Suicidal
- SLS-002
- +3 more
-
Tempe, Arizona
- +29 more
Jul 25, 2022
Dermatitis, Atopic Trial in Sheffield (2% urea/20% glycerol cream, Miniderm® 20% cream, Diprobase® cream)
Completed
- Dermatitis, Atopic
- 2% urea/20% glycerol cream
- +2 more
-
Sheffield, United KingdomThe University of Sheffield Medical School
Dec 13, 2021
Contact Allergy Trial (Rubber accelerators and control chamber/solution for NON-SLS group, SLS, Rubber accelerators and control
Not yet recruiting
- Contact Allergy
- Rubber accelerators and control chamber/solution for NON-SLS group
- +3 more
- (no location specified)
Sep 11, 2023
Sjögren-Larsson Syndrome Trial in Omaha, Hershey, Fairfax (Active topical NS2 1% dermatologic cream, Vehicle 0.0% NS2
Completed
- Sjögren-Larsson Syndrome
- Active topical NS2 1% dermatologic cream
- Vehicle placebo 0.0% NS2 dermatologic cream
-
Omaha, Nebraska
- +2 more
Nov 16, 2022
Single Leg Squat Test: A Cohort Study of Female Soccer Players.
Completed
- Functional Movement Disorders
- +2 more
- No intervention
-
Huddinge, SwedenKarolinska Institutet
Jan 25, 2023
Sjogren-Larsson Syndrome Trial in Omaha (ADX-629)
Recruiting
- Sjogren-Larsson Syndrome
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Nov 7, 2022
Diplegia Trial in Badr (Physical therapy program, scooter board activities)
Recruiting
- Diplegia
- Physical therapy program
- scooter board activities
-
Badr, Cairo, EgyptBadr University
Nov 2, 2022
Amyotrophic Lateral Sclerosis Trial in Boston (Trehalose)
Temporarily not available
- Amyotrophic Lateral Sclerosis
-
Boston, MassachusettsSean M. Healey & AMG Center for ALS Neurological Clinical Resear
Dec 14, 2022
Alzheimer's Disease Trial in Heidelberg, Shepparton, West Perth (SLS-005, Placebo)
Not yet recruiting
- Alzheimer's Disease
- SLS-005
- Placebo
-
Heidelberg, Victoria, Australia
- +2 more
Dec 23, 2022
Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)
Completed
- Hair Diseases
- +2 more
- DA-OTC-002
-
Manaus, BrazilHospital Oscar Nicolau
Oct 20, 2023
Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, NSCLC Trial (ELI-002 7P)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +14 more
- ELI-002 7P
- (no location specified)
Feb 3, 2023
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Jul 14, 2023
HER2 Mutant NSCLC, HER2-positive Metastatic Breast Cancer, HER2 Gene Mutation Trial (ELVN-002, Fam-Trastuzumab Deruxtecan-Nxki,
Not yet recruiting
- HER2 Mutant Non-small Cell Lung Cancer
- +3 more
- ELVN-002
- +2 more
- (no location specified)
Dec 6, 2022
Cognitive Change Trial in Coral Gables (Mindfulness-Based Attention Training (MBAT) web-course)
Enrolling by invitation
- Cognitive Change
- Mindfulness-Based Attention Training (MBAT) web-course
-
Coral Gables, FloridaUniversity of Miami
Aug 23, 2022
Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)
Completed
- Vaccine-Preventable Diseases
- Hepatitis B
- CVI-HBV-002
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofCHA University Bundang Medical Center
Nov 19, 2023
Healthy, Irritation/Irritant, Reactions Adverse Trial (NS Solution, Normal Saline, SLS)
Completed
- Healthy
- +2 more
- NS Solution
- +2 more
- (no location specified)
Nov 1, 2023
Refractory Focal Epilepsy Trial in Beijing (iPSC-Exos)
Recruiting
- Refractory Focal Epilepsy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 5, 2023
Hidradenitis Suppurativa, Atopic Dermatitis, Healthy Volunteer Trial (LT-002-158/Placebo oral tablet(s))
Not yet recruiting
- Hidradenitis Suppurativa
- +2 more
- LT-002-158/Placebo oral tablet(s)
- (no location specified)
Oct 9, 2023
Lymphatic Malformation Trial (TARA-002)
Not yet recruiting
- Lymphatic Malformation
- TARA-002
- (no location specified)
May 22, 2023
Spinocerebellar Ataxia Type 3 Trial in Los Angeles, Tampa (SLS-005, Placebo)
Recruiting
- Spinocerebellar Ataxia Type 3
- SLS-005
- Placebo
-
Los Angeles, California
- +1 more
Aug 4, 2022
Myopia Trial in Worldwide (NVK-002 Concentration 1, NVK-002 Concentration 2, Placebo)
Active, not recruiting
- Myopia
- NVK-002 Concentration 1
- +2 more
-
Tucson, Arizona
- +25 more
Jan 3, 2023
Autism Spectrum Disorder Trial in Staten Island (ML-004 (IR)/(ER) tablet)
Recruiting
- Autism Spectrum Disorder
- ML-004 (IR)/(ER) tablet
-
Staten Island, New YorkRichmond Behavioral Associates
Jun 1, 2023
Hemophilia B Trial in Russian Federation (ANB-002, dose 1, ANB-002, dose 2)
Recruiting
- Hemophilia B
- ANB-002, dose 1
- ANB-002, dose 2
-
Chelyabinsk, Russian Federation
- +14 more
Nov 4, 2023